Cyclin-Dependent Kinase Inhibitor-Associated Thromboembolism

JAMA Oncol. 2019 Feb 1;5(2):141-142. doi: 10.1001/jamaoncol.2018.5529.
No abstract available

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • Cyclin-Dependent Kinases / metabolism
  • Humans
  • Neoplasms / drug therapy*
  • Neoplasms / enzymology
  • Protein Kinase Inhibitors / adverse effects*
  • Risk Assessment
  • Risk Factors
  • Thromboembolism / chemically induced*
  • Thromboembolism / diagnosis
  • Thromboembolism / epidemiology

Substances

  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Cyclin-Dependent Kinases